Identification of Human S100A9 as a Novel Target for Treatment of Autoimmune Disease via Binding to Quinoline-3-Carboxamides

Despite more than 25 years of research, the molecular targets of quinoline-3-carboxamides have been elusive although these compounds are currently in Phase II and III development for treatment of autoimmune/inflammatory diseases in humans. Using photoaffinity cross-linking of a radioactively labelle...

Descripción completa

Detalles Bibliográficos
Autores principales: Björk, Per, Björk, Anders, Vogl, Thomas, Stenström, Martin, Liberg, David, Olsson, Anders, Roth, Johannes, Ivars, Fredrik, Leanderson, Tomas
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2009
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2671563/
https://www.ncbi.nlm.nih.gov/pubmed/19402754
http://dx.doi.org/10.1371/journal.pbio.1000097

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2671563/
https://www.ncbi.nlm.nih.gov/pubmed/19402754
http://dx.doi.org/10.1371/journal.pbio.1000097

Ejemplares similares